Burkholderia cepacia. Management issues and new insights (Q48766893)

15 February 2018

review article

1 reference

title

Burkholderia cepacia. Management issues and new insights (English)

1 reference

15 February 2018

1 reference

LiPuma JJ

1

1 reference

15 February 2018

publication date

1 September 1998

1 reference

15 February 2018

Clinics in Chest Medicine

published in

1 reference

15 February 2018

volume

19

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

page(s)

473-86, vi

1 reference

15 February 2018

The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome

cites work

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Longitudinal serum IgG response toPseudomonas cepacia surface antigens in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Case-Control and Vector Studies of Nosocomial Acquisition of Pseudomonas Cepacia in Adult Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Detection of Pseudomonas (Burkholderia) cepacia using PCR

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Substituted amines synergistic with tobramycin against Burkholderia cepacia in vitro

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Application of pyrolysis mass spectroscopy and SDS-PAGE in the study of the epidemiology of Pseudomonas cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Necrotizing Pneumonitis Due to the Pseudomonad Eugonic Oxidizer — Group I

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Survival of Burkholderia cepacia on environmental surfaces

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Colonization and. Infection with Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Source of Pseudomonas cepacia: Ribotyping of isolates from patients and from the environment

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pathogenic factors of Pseudomonas cepacia isolates from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Polyphasic Taxonomy in the Genus Burkholderia Leading to an Emended Description of the Genus and Proposition of Burkholderia vietnamiensis sp. nov. for N2-Fixing Isolates from Rice in Vietnam

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Burkholderia cepacia: medical, taxonomic and ecological issues

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Identifying the killer in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Lung transplantation for cystic fibrosis: special considerations

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Ribotype Stability of Serial Pulmonary Isolates of Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Transmission of Pseudomonas cepacia among cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia in inpatients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Nucleic Acid Homologies in the Genus Pseudomonas

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia in Lung Transplant Recipients With Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Isolation of a novel siderophore from Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas Species Bacteremia Caused by Contaminated Normal Human Serum Albumin

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Transmissibility of Pseudomonas cepacia Infection in Clinic Patients and Lung-Transplant Recipients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

The emergence of a highly transmissible lineage of cbl Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

1 reference

7 January 2021

Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Transfer of TwoBurkholderiaand AnAlcaligenesSpecies toRalstoniaGen. Nov.

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

Occurrence of Multiple Genomovars of Burkholderia cepacia in Cystic Fibrosis Patients and Proposal of Burkholderia multivorans sp. nov

1 reference

https://api.crossref.org/works/10.1016/S0272-5231(05)70094-0

7 January 2021

10.1016/S0272-5231(05)70094-0

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018